Publikationen, an denen er mitarbeitet Miguel Ángel González Torres (20)

2021

  1. Real clinical setting intravenous ketamine use for treatment resistant depression: 12 month follow-up after initial response

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 4, pp. 227-229

2020

  1. Can childhood trauma influence facial emotion recognition independently from a diagnosis of severe mental disorder?

    Revista de Psiquiatria y Salud Mental, Vol. 13, Núm. 3, pp. 140-149

  2. Los fenómenos de posesión: A propósito de un caso

    Actas Espanolas de Psiquiatria

  3. Possession Phenomena: a Case Report

    Actas espanolas de psiquiatria, Vol. 48, Núm. 2, pp. 89-98

2018

  1. Affectively salient signal to random noise might be used to identify psychosis vulnerability in severe mental disorders

    European Psychiatry, Vol. 49, pp. 37-42

  2. The relationship between theory of mind deficits and neurocognition in first episode-psychosis

    Psychiatry Research, Vol. 268, pp. 361-367

2017

  1. Relation between psychotic symptoms, parental care and childhood trauma in severe mental disorders

    Psychiatry Research, Vol. 251, pp. 78-84

2016

  1. COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients

    Pharmacogenomics, Vol. 17, Núm. 8, pp. 837-851

  2. Depresión psicótica y catatonía crónica resistentes a terapia electroconvulsiva. Descripción de un caso de tratamiento con ketamina

    Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, Vol. 23, Núm. 1, pp. 36-39

  3. Differences in facial emotion recognition between first episode psychosis, borderline personality disorder and healthy controls

    PLoS ONE, Vol. 11, Núm. 7

2015

  1. Data gathering bias: Trait vulnerability to psychotic symptoms?

    PLoS ONE, Vol. 10, Núm. 7

  2. Erratum: Data Gathering Bias: Trait Vulnerability to Psychotic Symptoms? (PLoS ONE (2015) 10:8 (e0135761))

    PLoS ONE

  3. Undertreatment of human immunodeficiency virus in psychiatric inpatients: A cross-sectional study of seroprevalence and associated factors

    Neuropsychiatric Disease and Treatment, Vol. 11, pp. 1421-1426

2014

  1. Impact of the creation and implementation of a clinical management guideline for personality disorders in reducing use of mechanical restraints in a psychiatric inpatient unit

    Primary Care Companion to the Journal of Clinical Psychiatry, Vol. 16, Núm. 6

  2. Novel evidence hat attributing affectively salient signal to random noise is associated with psychosis

    PLoS ONE, Vol. 9, Núm. 7

2011

  1. Catatonia: a propósito de un caso

    Revista de la Asociación Española de Neuropsiquiatría, Vol. 31, Núm. 109, pp. 111-119

  2. Variability of plasma homovanillic acid over 13 months in patients with Schizophrenia; Relationship with the clinical response and the wisconsin card sort test

    Neurochemical Research, Vol. 36, Núm. 8, pp. 1336-1343

2010

  1. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients

    Neurochemistry International, Vol. 56, Núm. 6-7, pp. 774-779

  2. Depersonalization in patients with schizophrenia spectrum disorders, first-degree relatives and normal controls

    Psychopathology, Vol. 43, Núm. 3, pp. 141-149

2004

  1. Investigación cualitativa en esquizofrenia. Un estudio con grupos focales para conocer experiencias de discriminación de pacientes y familiares

    Archivos de Psiquiatria, Vol. 67, Núm. 3, pp. 211-220